Molecular-based testing technology has shortest processing time of any multiplex microbial assay accepted by a regulatory agency
Gibco CTS TrueCut Cas9 Protein supports use of genome editing for research and manufacturing applications, including CAR T-cell therapy research
The innovative instrument helps clinical flow cytometry labs automate end-to-end sample preparation
Discover the latest tools and techniques to expand your research capacity with expert-led presentations on chromatography, drug discovery, biosafety, and more
Porvair’s growing range of Chromatrap® ChIP kits for epigenetics research show promise
UCLA scientists’ confirmation of this process clarifies a longstanding controversy about blood stem cells’ cellular origin
In this article, you will find some of the pivotal research presented at the AACR annual meeting
Ziath to launch two new innovative sample management products at Analytica 2022
New adaptor kit simplifies and improves the speed of Acoustix tube picking
The Mohawk tube selector and picker from Ziath is designed to provide an intuitive interface for fast and effortless operation without the need for a fully-robotic system
Agilent Technologies showcased its cancer research innovations in cell analysis and genomics at the American Association for Cancer Research Annual Meeting
The peptide-based vaccine induces a T cell-dependent response
The epigenomic signature is evident prior to CD19-targeted CAR T-cell treatment
Latinos are also more likely to be diagnosed with this cancer type
Program participants will receive early access to the upcoming release of kits designed to print longer oligos and enable labeling with fluorophores, quenchers, and biotin
The cutting-edge technique aims to detect and prevent wine fraud by verifying wine identity
For the correlative analysis of Raman, AFM, AFM-Raman, cathodoluminescence and fluorescence data and microscopy images
Researchers have developed risk prediction algorithms for many forms of cancer as a result of recent breakthroughs in AI
Researchers have demonstrated that the adverse effects of combination therapy could be predicted
The identification of this genetic variant could help select lung cancer patients who may be at risk of more severe autoimmune side effects
